Consider Afrezza as an Alternative to Mealtime Insulin Injections

March 2015

Afrezza (uh-FREZ-uh) will be a new INHALED insulin for diabetes.

The first inhaled insulin, Exubera, didn't pan out...partly because the inhaler was hard to use and about the size of a tennis ball can.

Afrezza is easier to use...and about the size of a whistle.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote